| Muscle Cell News 4.42 December 16, 2019 | |
|
|
|
|
TOP STORYMutant Lamins Cause Nuclear Envelope Rupture and DNA Damage in Skeletal Muscle Cells Using three mouse models of muscle laminopathies and muscle biopsies from individuals with LMNA-related muscular dystrophy, investigators found that Lmna mutations reduced nuclear stability and caused transient rupture of the nuclear envelope in skeletal muscle cells, resulting in DNA damage, DNA damage response activation and reduced cell viability. [Nat Mater] Abstract |
|
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSA Spatiotemporal Organ-Wide Gene Expression and Cell Atlas of the Developing Human Heart Researchers present a molecular approach that reveals the comprehensive transcriptional landscape of cell types populating the embryonic heart at three developmental stages and that maps cell-type-specific gene expression to specific anatomical domains. Spatial transcriptomics identified unique gene profiles that corresponded to distinct anatomical regions in each developmental stage. [Cell] Abstract | Graphical Abstract Loss of ADAMTS19 Causes Progressive Non-Syndromic Heart Valve Disease Expression analysis using a lacZ reporter and single-cell RNA sequencing highlight Adamts19 as a novel marker for valvular interstitial cells; inference of gene regulatory networks in valvular interstitial cells positions Adamts19 in a highly discriminatory network driven by the transcription factor lymphoid enhancer-binding factor 1 downstream of the Wnt signaling pathway. [Nat Genet] Abstract Scientists found that the deletion of myostatin (MSTN) potentiated abdominal aorta coarctation (AAC) and Ang II-induced pathological cardiac hypertrophy and cardiac autophagy; however, AAC and Ang II-induced cardiac hypertrophic phenotype and cardiac autophagy were dramatically diminished by MSTN in vivo and in vitro. [Mol Ther Nucleic Acids] Abstract | Full Articles Defined Factors to Reactivate Cell Cycle Activity in Adult Mouse Cardiomyocytes Investigators established conditions for long-term culture of adult mouse cardiomyocytes that are genetically labeled with fluorescence. This technique permitted reliable analyses of proliferation of pre-existing cardiomyocytes without complications from cardiomyocyte marker expression loss due to dedifferentiation or significant contribution from cardiac progenitor cell expansion and differentiation in culture. [Sci Rep] Full Article SKELETAL MUSCLE CELLSThe definitive muscle-regulatory T cells (Tregs) transcriptome was not established until transgenic Tregs inhabited muscle. When crossed onto a mdx model of Duchenne muscular dystrophy, the muscle-Treg TCR transgenes drove enhanced accumulation of Tregs in hindlimb muscles and improved muscle regeneration. [Proc Natl Acad Sci USA] Abstract DEPDC1B Is a Key Regulator of Myoblast Proliferation in Mouse and Man Expression dynamics of DISHEVELLED, EGL-10, PLECKSTRIN domain-containing 1B (DEPDC1B) were examined in murine and human myoblasts and rhabdomyosarcoma cells in vitro by RT-qPCR and/or immunolabeling. DEPDC1B function was mainly tested via siRNA-mediated gene knockdown. [Cell Prolif] Full Article The authors examined the pathological mechanism(s) of a mutant stromal interaction molecule 1 (R429C) that causes human muscular hypotonia. R429C was expressed in mouse primary skeletal myotubes, and the properties of the skeletal myotubes were examined using single-cell Ca2+ imaging of myotubes and transmission electron microscopy along with biochemical approaches. [Sci Rep] Full Article Publicly available datasets were used to profile mRNA levels in myotubes and skeletal muscle tissues. L6, C2C12 and human skeletal muscle cells myotubes were assessed for proliferation, glucose uptake, glycogen synthesis, mitochondrial activity, and substrate oxidation, as well as the response to in vitro contraction. [Am J Physiol Cell Physiol] Abstract SMOOTH MUSCLE CELLSIndirect and direct adipose-derived stem cell (ASC)-vascular smooth muscle cell (VSMC)-monocyte co-cultures were constructed within a porous polyurethane scaffold previously shown to have an immunomodulatory character. The effects of monocytes/macrophages on the cellularity, extracellular matrix accumulation as well as the maintenance of contractile VSMC markers of the ASC-VSMCs after a month of co-culture were investigated. [Acta Biomater] Abstract | Graphical Abstract The suitability of photoactive surfaces for intravascular photodynamic therapy (PDT) was tested in two cell lines relevant to stent implantation: vascular endothelial cells and vascular smooth muscle cells. It was demonstrated that two hour incubation on silica matrices was sufficient for uptake of the encapsulated photosensitizers. [Materials] Abstract | Graphical Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & ESC & iPSC News. |
|
|
|
|
REVIEWSDystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy The authors describe brain involvement in Duchenne muscular dystrophy (DMD) and the abnormalities observed in the DMD brain. They then review the gene expression, RNA processing and functions of Dp71. They review genotype-phenotype correlations and discuss emerging cellular/tissue evidence for the involvement of Dp71 in the neuropathophysiology of DMD. [Mol Neurobiol] Abstract The neuromuscular junction is the synapse between a motor neuron of the spinal cord and a skeletal muscle fiber in the periphery. Reciprocal interactions between these excitable cells, and between them and others cell types present within the muscle tissue, shape the development, homeostasis and plasticity of skeletal muscle. [Neurosci Lett] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. |
|
|
|
|
INDUSTRY NEWSCatabasis Pharmaceuticals Announces Phase III PolarisDMD Trial Enrolled Expected Patient Population Catabasis Pharmaceuticals, Inc. announced the results from an analysis of the baseline characteristics of the Phase III PolarisDMD trial of edasalonexent in Duchenne muscular dystrophy (DMD). The analysis shows that overall the patients enrolled in the Phase III trial have similar characteristics to the patients that enrolled in the previous Phase II MoveDMD trial. [Catabasis Pharmaceuticals, Inc.] Press Release Sarepta Therapeutics, Inc. announced that the FDA has approved VYONDYS 53™. VYONDYS 53 is an antisense oligonucleotide from Sarepta’s phosphorodiamidate morpholino oligomer platform, indicated for the treatment of DMD in patients with a confirmed mutation amenable to exon 53 skipping. [Sarepta Therapeutics, Inc.] Press Release Wave Life Sciences Ltd. announced its decision to discontinue development of suvodirsen for patients with Duchenne muscular dystrophy (DMD) who have mutations amenable to exon 51 skipping, based on its interim analysis of the Phase I open-label extension study. The results showed no change from baseline in dystrophin expression, as measured by western blot, with either the 3.5 mg/kg or 5 mg/kg doses of suvodirsen. [Wave Life Sciences Ltd.] Press Release | |
|
|
|
POLICY NEWSUK Election Dashes Scientists’ Hopes of Staying in the EU The United Kingdom is now firmly on the path towards leaving the European Union, after the Conservative party won a majority of 79 seats in yesterday’s general election – a result that has major implications for science. [Nature News] Editorial United States Drops Charges against Two More Scientists after Iran Prisoner Swap US authorities have dropped charges against two researchers accused of attempting to export chemicals to Iran in violation of trade sanctions. The decision follows a prisoner swap in which the United States freed a third researcher who was charged alongside them – and imprisoned. [Nature News] Editorial
|
|
EVENTSNEW Lorne Cancer Conference Visit our events page to see a complete list of events in the community.
|
|
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Computation Systems and Skeletal Muscles (University of Luxembourg) Postdoctoral Researcher – Muscle Stem Cell Biology (University at Albany) Postdoctoral Researcher – Skeletal Muscle Aging (St. Jude Children’s Research Hospital) Senior Scientist – Muscle Cell Biology (Shape Therapeutics) Asistant Professor – Ion Channels (University of Tennessee) Assistant Professor – Muscle Biology (Purdue University) Postdoctoral Researcher – Larnygeal Muscle Development (Columbia University) Postdoctoral Researcher – Genome Editing in Cardiac Microtissues (The Jackson Laboratory) Research Scientists – Cardiac and Neuronal Cell Differentiation (Evotec) Research Scientist – Metabolic & Muscle Diseases (Regeneron) Assistant Specialist – Cardiovascular Medicine (University of California, Davis)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News


